名称をさらに表示
ブリオデュロコシゲニン(9β,10α)-3β,24,25-トリヒドロキシ-9-メチル-19-ノルラノスタ-5-エン-11-オン(1R,3aS,3bS,7S,9aR,9bR,11aR)-1-[(2R)-5,6-ジヒドロキシ-6-メチルヘプタン-2-イル]-7-ヒドロキシ-3a,6,6,9b,11a-ペンタメチル-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-シクロペンタ[a]フェナントレン-10-オンBryodulocosigeninBryodulcosigenin, 10 mM in DMSOinhibit,Bryodulcosigenin,Inhibitor(9β,10α)-3β,24,25-Trihydroxy-9-methyl-19-norlanost-5-en-11-one19-Norlanost-5-en-11-one, 3,24,25-trihydroxy-9-methyl-, (3β,9β,10α)-
(9|A,10|A)-3|A,24,25-Trihydroxy-9-methyl-19-norlanost-5-en-11-one1-(5,6-dihydroxy-6-methylheptan-2-yl)-7-hydroxy-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-10-one17-(4,5-dihydroxy-1,5-dimethyl-hexyl)-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one